DrugPatentWatch Database Preview
Profile for Serbia Patent: 50996
» See Plans and Pricing
US Patent Family Members and Approved Drugs for Serbia Patent: 50996
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
Start Trial | Apr 18, 2029 | Eisai Inc | BELVIQ XR | lorcaserin hydrochloride |
Start Trial | Apr 18, 2029 | Eisai Inc | BELVIQ | lorcaserin hydrochloride |
Start Trial | Dec 20, 2025 | Eisai Inc | BELVIQ XR | lorcaserin hydrochloride |
Start Trial | Dec 20, 2025 | Eisai Inc | BELVIQ | lorcaserin hydrochloride |
Start Trial | Dec 20, 2025 | Eisai Inc | BELVIQ XR | lorcaserin hydrochloride |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |